推 duckcomtw: 推 06/11 07:27
ASCO 英文摘要如下:
An observational cohort study on terminal cancer survivors practicing falun go
ng (FLG) in China.
http://goo.gl/CX1pVY
Sub-category:
Survivorship
Category:
Patient and Survivor Care
Meeting:
2016 ASCO Annual Meeting
Abstract No:
e21568
Citation:
J Clin Oncol 34, 2016 (suppl; abstr e21568)
Author(s): Yuhong Dong, Chian-Feng Huang, Jim Liao, Alex Chih-Yu Chen, Jason G
. Liu, Kai-Hsiung Hsu; Novartis, Basel, Switzerland; Institute of Epidemiology
and Preventive Medicine, National Taiwan University, Taipei, Taiwan; Gillings
School of Public Health, University of North Carolina, Chapel Hill, NC; Imper
ial College London, London, United Kingdom; Mind-Body Science Institute, South
Pasadena, CA; National Ilan University, Ilan, Taiwan
Abstract Disclosures
Abstract:
Background: In China, cancer patients may choose to practice FLG -- the most p
opular Qigong since 1992 -- after treatment failure, arousing great interest i
n the medical society. Methods: We collected reports from Chinese cancer patie
nts between 2000 and 2015 via a web platform, including diagnosis, FLG practic
e duration, Actual Survival (AS) till report date, symptom improvement, and Qu
ality of Life (QoL). All reports were reviewed by 2 physicians. Predicted Surv
ival (PS) was assessed using the NIH SEER data if the treating physician’s Cl
inical Prediction of Survival (CPS) was unavailable. Reports of terminal cance
r patients (PS 12 months) with sufficient and verifiable medical informatio
n were considered eligible. Symptom Free Survival (SFS) was also calculated. R
esults: In the web database, using the search terms late-stage and “cancer, w
e found 406 prospective cases, wherein 152 terminal cases (PS 12 months) we
re deemed eligible. Primary cancer types included lung (n = 38), liver (n = 29
), stomach (n = 17), leukemia (n = 12), esophagus (n = 10), gynecological (n =
9), pancreas/bile duct (n = 8), colorectal (n = 7), and others (n = 22). The
onset age was 53.3?15.6 years. Among them, 65 patients experienced cancer trea
tment failure, 74 patients did not take any further cancer treatment after dia
gnosis, and 13 patients received treatment along with FLG practice. The FLG pr
actice duration was 53.1?58.9 months. As of the report date, 149 patients were
still alive. Compared with PS (5.1?2.7 months), AS was significantly prolonge
d to 56.0?60.1 months (P < 0.0001). CPS (5.1?2.0 months) was close to SEER sur
vival (5.2?3.2 months), indicating the reliability of CPS and these reports. T
ime to Effect was 1.3?1.7 months. A total of 147 patients (96.7%) reported com
plete symptom recovery with 60 patients confirmed by treating physicians. Time
to Symptom Recovery was 3.6?3.3 months, and SFS was 52.7?61.1 months. QoL aft
er FLG practice significantly improved (all Ps < 0.0001). Multivariate analysi
s showed FLG practice duration was the dominating predictive factor for AS and
SFS. Conclusions: We observed that FLG practice can help terminal cancer pati
ents survive significantly longer, in addition to notable symptom improvement.
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 114.36.115.217
※ 文章網址: https://www.ptt.cc/bbs/FaLunDaFa/M.1465564894.A.D83.html
※ 編輯: ksjksj (114.36.115.217), 06/10/2016 21:38:08
※ 編輯: ksjksj (114.36.115.217), 06/10/2016 21:54:34